% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

  • kyle.ramer kyle.ramer May 14, 2013 11:20 AM Flag

    upcoming catalyst and dates for next 6 months for new investors

    INO-5150 SynCon Prostate cancer Initiate phase I clinical trial (2013)
    Here is a list of what ino has in the pipeline coming out the next 6 months, dates are always subject to change, and the bio defense projects ino has are often kept quite about until completed,
    Big pharma partnership(2013) expected according to CEO Joseph Kim

    PENNVAX-B is designed treat and prevent HIV Final HIV-001 results expected in 1H 2013

    PENNVAX-GP HIV type-1 clades A and C Initiate phase I clinical trial in 2013

    Seasonal Flu (H1N1, elderly) Report interim phase I clinical data (2013)

    DNA vaccine for leukemia Additional phase II data (2013)

    Hepatitis C virus therapeutic INO-8000 Phase I/IIa clinical trial in HCV infected individuals (4Q 2013)

    VGX-3100 SynCon® vaccine for cervical dysplasia/cancer Enrolling international phase II study; expect results 1Q 2014

    SynCon® vaccines against malaria, foot-and-mouth disease (for animals), dengue fever, Chikungunya virus, and other tropical infectious diseases, some which pose potential risk for bioterrorism use.
    (dates for us military funded projects aren't listed and often results come out randomly like they have recently)

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.8301-0.1599(-2.29%)1:16 PMEDT